Abdelmalik Bishoy M, Hao Kevin A, Turnbull Lacie M, Wright Thomas W, Wright Jonathan O, Farmer Kevin W, Pazik Marissa, King Joseph J
College of Medicine, University of Florida, Gainesville, FL, USA.
Department of Orthopaedic Surgery and Sports Medicine, University of Florida, Gainesville, FL, USA.
J Shoulder Elbow Surg. 2023 Jan;32(1):e1-e10. doi: 10.1016/j.jse.2022.06.030. Epub 2022 Aug 13.
Patient survivorship and risk factors of mortality after reverse total shoulder arthroplasty (RTSA) are seldom and inadequately studied. The purpose of this study was to evaluate the mortality rates and predictors of 1-year and overall mortality after RTSA.
We retrospectively reviewed 1518 consecutive adult patients who underwent RTSA at our institution. The Social Security Death Index and institutional electronic medical records were queried to verify patient living status. Patients were censored at date of death if deceased, the date that living status was verified if alive, or latest follow-up if living status could not be verified. Mortality rates and risk factors of 1-year and overall mortality after RTSA were identified on univariate and multivariate analysis.
Mean follow-up was 5.1 ± 3.8 years. Thirty-day (0.1%), 90-day (0.7%), and 1-year (1.8%) mortality rates were low but increased to 11% at 5 years. Increased odds of 1-year mortality were independently associated with heart disease (odds ratio [OR] 2.64, 95% confidence interval [CI] 1.07-6.50, P = .035) and use of a cemented stem (OR 2.64, 95% CI 1.04-6.69, P = .041). Independent risk factors of overall mortality included older age at surgery (hazard ratio [HR] 1.05, 95% CI 1.03-1.07, P < .001), minority ethnicity (protective risk factor, HR 0.37, 95% CI 0.15-0.91, P = .031), heart disease (HR 1.42, 95% CI 1.00-2.02, P = .048), diabetes mellitus (HR 1.47, 95% CI 1.04-2.08, P = .028), tobacco use (HR 1.79, 95% CI 1.08-2.98, P = .025), post renal transplant (HR 12.69, 95% CI 3.92-41.05, P < .001), chronic liver failure (HR 4.40, 95% CI 1.38-14.09, P = .013), and receiving a cemented stem (HR 1.60, 95% CI 1.13-2.26, P = .008).
RTSA carries a low risk of short-term mortality postoperatively. When counseling patients preoperatively, surgeons should consider the predictors of mortality after RTSA reported herein to ensure appropriate patient selection and counseling.
关于反式全肩关节置换术(RTSA)后患者的生存情况及死亡风险因素的研究较少且不够充分。本研究的目的是评估RTSA后1年及总体死亡率以及死亡预测因素。
我们回顾性分析了在本机构连续接受RTSA的1518例成年患者。查询了社会保障死亡指数和机构电子病历以核实患者的生存状态。若患者已死亡,则在死亡日期进行截尾;若存活,则在生存状态核实日期进行截尾;若无法核实生存状态,则在最近一次随访时进行截尾。通过单因素和多因素分析确定RTSA后1年及总体死亡率和风险因素。
平均随访时间为5.1±3.8年。30天(0.1%)、90天(0.7%)和1年(1.8%)的死亡率较低,但5年时升至11%。1年死亡率增加的几率与心脏病(优势比[OR]2.64,95%置信区间[CI]1.07 - 6.50,P = 0.035)和使用骨水泥柄(OR 2.64,95%CI 1.04 - 6.69,P = 0.041)独立相关。总体死亡的独立风险因素包括手术时年龄较大(风险比[HR]1.05,95%CI 1.03 - 1.07,P < 0.001)、少数族裔(保护风险因素,HR 0.37,95%CI 0.15 - 0.91,P = 0.031)、心脏病(HR 1.42,95%CI 1.00 - 2.02,P = 0.048)、糖尿病(HR 1.47,95%CI 1.04 - 2.08,P = 0.028)、吸烟(HR 1.79,95%CI 1.08 - 2.98,P = 0.025)、肾移植术后(HR 12.69,95%CI 3.92 - 41.05,P < 0.001)、慢性肝衰竭(HR 4.40,95%CI 1.38 - 14.09,P = 0.013)以及使用骨水泥柄(HR 1.60,95%CI 1.13 - 2.26,P = 0.008)。
RTSA术后短期死亡风险较低。在术前对患者进行咨询时,外科医生应考虑本文报道的RTSA后死亡预测因素,以确保进行适当的患者选择和咨询。